Henan Jiyuan Donglingcao Pharmaceutical

Henan Jishi Pharmaceutical Co., Ltd., formerly known as Henan Jiyuan Donglingcao Pharmaceutical Co., Ltd., is a leading Chinese pharmaceutical company specializing in Traditional Chinese Medicine (TCM). Based in Jiyuan, Henan, the company leverages the region's status as the primary source of Rabdosia rubescens (Donglingcao) to produce a wide range of herbal products. Its flagship offerings include exclusive national products such as Compound Donglingcao Lozenges, alongside tablets, syrups, and capsules used for treating inflammatory conditions like pharyngitis and tonsillitis. The company's products also serve as adjuvant therapy for esophageal and gastric cancers, utilizing the anti-tumor properties of the active compound oridonin. Recognized as a national high-tech enterprise, the company operates several provincial-level research centers and maintains academic collaborations with the Chinese Academy of Sciences to advance the modernization of herbal medicine.